Search results for: Human PLGF ELISA ELISA
#31265210 // Save this To Up
Effects of VEGF inhibitors on human retinal pigment epithelium under high glucose and hypoxia.Retinal pigment epithelium (RPE) is known to secrete factors important for retinal homeostasis. How this secretome changes in diabetic eyes treated with anti-vascular endothelial growth factor (VEGF) inhibitors is unclear.
1318 related Products with: Effects of VEGF inhibitors on human retinal pigment epithelium under high glucose and hypoxia.ELISA Human , Pigment Epi Rabbit Anti-Human Androge Anti Human, mab VEGFR 1 F Apoptosis (Human) Antibod Inflammation (Human) Anti Recombinant Human VEGF-12 Anti Human, mab VEGFR 2 K Cytokine (Human) Antibody Rabbit Anti-Human VEGFR1 Cytokine (Human) Antibody ElISA Human , Interleukin Rabbit anti VEGFR-2 KDR (
#31185956 // Save this To Up
What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.The aim of the present study was to evaluate the efficacy and safety of intravitreal conbercept combined with trabeculectomy and panretinal photocoagulation for neovascular glaucoma (NVG).
1330 related Products with: What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.Rabbit Anti-CSNK1D Casein Normal rat multiple organ anti-Casein Kinase II α Multiple organ tumor tiss Oncocytoma tissue array, FDA Standard Frozen Tissu Normal rat multiple organ anti-Casein kinase II β Rabbit Anti-CSNK1D Casein Multiple organ cancer tis anti-Casein Kinase II α Tissue array of ovarian g
#31177907 // Save this To Up
Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including Preeclampsia.The mineralocorticoid aldosterone increases in plasma in healthy pregnancy along with renin and angiotensin II and plays a key role in the physiological plasma volume expansion. In mice, aldosterone contributes to an optimal fetal development by enhancing PlGF (placental growth factor) expression and trophoblast cell proliferation. In preeclampsia, there is coincident suppression of aldosterone and impaired placental development. We hypothesized that aldosterone independently contributes to placental and birth weight in humans, and high dietary sodium and low potassium intakes affect this relationship adversely. We analyzed 24-hour urine collections and plasma samples from gestational week 29 in a subsample of 569 pregnant women from the Odense Child Cohort-a Danish population-based longitudinal cohort study. Plasma and urinary aldosterone were measured by ELISA, sodium and potassium excretions by flame photometer. Predictive values of aldosterone levels and sodium and potassium intakes were assessed by multiple and Cox regression analyses. Primary outcomes were placental weight and birth weight. Secondary outcome was preeclampsia. Urinary aldosterone excretion at gestational week 29 independently contributed to placental and birth weights (adjusted β-coefficients [95% CI], 24.50 [9.66-39.35] and 9.59 [4.57-14.61], respectively). Aldosterone levels were not associated to preeclampsia incidence. Salt intake >6 g/d was associated with development of preeclampsia (hazard ratio [95% CI], 5.68 [1.51-21.36]). At gestational week 29, urinary aldosterone excretion is an independent predictor of placental and birth weights. High salt intake is a risk factor for preeclampsia. In perspective, suppression of aldosterone in pregnancy has adverse trophic effects.
1466 related Products with: Aldosterone, Salt, and Potassium Intakes as Predictors of Pregnancy Outcome, Including Preeclampsia.6 para Toluidino 2 naphth 5 Amino 1(H) tetrazole po Acesulfame-d4 Potassium S 2-(Aminocarbonyl)-3-nitro Quest Fluo 8L™, potassi MES Potassium salt CAS Nu Cal-520FF™, potassium s Losartan potassium salt C 8 Octadecyloxypyrene 1,3, D Luciferin, potassium sa (R)-Apomorphine-10-sulfat L Aspartic acid magnesium
#30801711 // Save this To Up
Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.To compare serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) concentrations among women with pre-eclampsia and healthy control women and to evaluate the associations of serum PlGF and sFlt-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
2332 related Products with: Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.Sterile filtered fetal bo Sterile filtered fetal bo Sterile filtered fetal bo Sterile filtered fetal bo Sterile filtered fetal bo Rat Insulin-like Growth F Sterile filtered fetal bo Mouse Insulin-like Growth Sterile filtered fetal bo Sterile filtered fetal bo Sterile filtered fetal bo Human Insulin-like Growth
#30591201 // Save this To Up
Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.Tumor necrosis factor-alpha (TNF- α) promotes tumor growth by enhancing tumor angiogenesis; however, the effects on choriocarcinoma remain unknown. We investigated the effects of TNF-α on the production of placental growth factor (PlGF) and vascular endothelial growth factor-A (VEGF-A) in BeWo cells and also examined its significance on the interactions with the endothelial cells by using human umbilical vein endothelial cells (HUVECs).
2083 related Products with: Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.Human, Complement C1q tum Human Tumor Necrosis Fact TNFRSF1B - Goat polyclona Tumor necrosis factor (TN Human Tumor Necrosis Fact Human Tumor necrosis fact ELISA Kit for Tumor Necro Mouse Tumor Necrosis Fact ELISA Kit for Tumor Necr Mouse Tumor Necrosis Fact ELISA p55,p60,Pig,Sus scr Human Tumor Necrosis Fact
#30527108 // Save this To Up
Serum soluble LIGHT in the early third trimester as a novel biomarker for predicting late-onset preeclampsia.Our aim was to evaluate whether serum levels of soluble LIGHT (sLIGHT) at 27-31 weeks can predict the later occurrence of gestational hypertension (GH), late-onset preeclampsia (PE), and early-onset PE. Mean blood pressure (MBP), soluble fma-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF) ratio at 27-31 weeks, and sLIGHT at 27-31 weeks were independent risk factors for late-onset PE. The combination of the three risk factors improved sensitivity with a false-positive rate of 10% (MBP: 60%, log(sFlt-1/PlGF): 45%, sLIGHT: 35%, combination: 75%). Serum sLIGHT in the early third trimester may be a novel biomarker for predicting late-onset PE.
2660 related Products with: Serum soluble LIGHT in the early third trimester as a novel biomarker for predicting late-onset preeclampsia.Triglyceride Assay Kit Li MMP-1 Inhibitor Screening Cell Meter™ Fluorimetri Amplite™ Intracellular MMP13 inhibitor assay kit Cultrex 24 Well Collagen FDA Standard Frozen Tissu Caspase 8 Inhibitor Drug Thermal Shaker with cooli DPP IV Inhibitor, K 579; Late stage breast cancer Endothelial Tube Formatio
#30310263 // Save this To Up
Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells.Systemic hypertension is a risk factor of neovascular age-related macular degeneration; consumption of dietary salt resulting in extracellular hyperosmolarity is a main cause of hypertension. Extracellular hyperosmolarity was shown to induce expression of angiogenic growth factors, such as vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), in RPE cells. The aim of the present study was to determine whether the hyperosmotic expression of growth factor genes in RPE cells is mediated by activator protein-1 (AP-1), and whether c-Fos and c-Jun genes are regulated by extracellular osmolarity.
2761 related Products with: Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells.Rabbit Anti-Cell death in Anti-ARID2(AT-rich intera Rabbit Anti-TNIP2 ABIN2 T Rabbit Anti-TNIP2 ABIN2 T Rabbit Anti-APIP Apaf1 In Anti-AICDA(Activation-ind TGF beta induced factor 2 Rabbit Anti-G protein alp Rabbit Anti-APIP Apaf1 In Rabbit Anti-G protein alp Rabbit Anti-Cell death in Polyclonal Antibody Recep
#30195493 // Save this To Up
Activation of brown adipocytes by placental growth factor.Gestational diabetes mellitus (GDM) is a type of diabetes and occurs during pregnancy. Brown adipose tissue (BAT) improves glucose homeostasis and mitigates insulin resistance, however, its activity is reduced in GDM. Placenta growth factor (PlGF) is an angiogenic factor produced by placental trophoblasts. Nevertheless, whether and how PlGF could affect BAT function in GDM are not defined. To investigate this question, 91 non-diabetic pregnant participants and 73 GDM patients were recruited to Gynaecology and Obstetrics Centre in Lu He hospital. Serum levels of PlGF were quantified by ELISA. Skin temperature was measured by far infrared thermography in the supraclavicular region where classical BATs were located. The direct effect of PlGF on BAT function was explored using the established human preadipocyte differentiation system. Thereby, we demonstrated that serum levels of PlGF were lower in GDM patients compared with controls, which was accompanied by decreased skin temperature in the supraclavicular region. By qPCR and western blot, mRNA and protein expression of UCP1 and OXPHOS were elevated in differentiated adipocytes treated with PlGF. PlGF stimulated mitochondrion transcription and increased copy number of mitochondrial. When subjected for respirometry, PlGF-treated differentiated adipocytes showed higher oxygen consumption rates than controls. PlGF induced AMPK phosphorylation and blockade of AMPK phosphorylation blunted UCP1 and OXPHOS expression in differentiated adipocytes. PlGF administration reduced cholesterol and triglyceride content in the liver and improved insulin sensitivity in db mice compared with control. In Conclusion, PlGF could activate BAT function. Downregulation of PlGF might contribute to the reduced BAT activity in GDM.
Human Transforming Growth Epidermal Growth Factor ( Keratinocyte Growth Facto Rabbit Placenta Growth Fa CELLKINES PLATELET DERIVE Mouse Insulin-like Growth Human, Fibroblast Growth Rat Vascular Endothelial Human Insulin-like Growth Rabbit Polyclonal Antibod Cultrex BME, reduced grow Human Fibroblast Growth F
#30194878 // Save this To Up
Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR4-dependent.While diabetes and APS are individually associated with increased risk of poor perinatal outcomes, in particular preeclampsia, recent studies have demonstrated an association between concurrent aPL and diabetes leading to an increased risk of pregnancy morbidity. Hyperglycemia and aPL have independently been shown to alter human trophoblast function by inducing a pro-inflammatory, anti-angiogenic, and antimigratory response. However, little is known about the effects of concurrent hyperglycemia and aPL on trophoblast function.
1357 related Products with: Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR4-dependent.Goat Anti-Human Glutathio Native Influenza HA (A So HIV1 integrase antibody, Goat Anti-Human Nur77 TR3 Goat Anti-Human Laforin ( Goat Anti-Human SLIMMER F Goat Anti-Human NHERF2 (i Goat Anti-Human MBD2 (iso Goat Anti-Human NHERF2 (i Goat Anti- TRIM5 RNF88 (a Goat Anti-Human MDM2 (iso Goat Anti-Human LAX, (int
#30177039 // Save this To Up
The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.The objective of this study was to investigate soluble epidermal growth factor receptor (sEGFR), soluble vascular endothelial growth factor receptor 1 (sFlt-1), soluble endoglin (sEndoglin) and placenta growth factor (PLGF) concentrations in normotensive, preterm and term preeclamptic pregnancies' serum and thus to specify the clinical utility of these biochemical markers in monitoring severity and intrauterine growth retardation of preterm preeclampsia. 172 pregnant women were divided into the following groups: preterm preeclampsia, preterm control, term preeclampsia and term control. Preterm preeclampsia patients were stratified with severe feature (n = 50) and without severe feature (n = 22). sEGFR, sEndoglin and PLGF were assessed using Luminex multiplex immunoassay, whilesFlt-1 was assessed using ELISA. sEGFR was significantly lower in preterm preeclampsia than matched control (p < 0.001) and mildly lower in term preeclampsia than matched control (p < 0.01). On contrary, sFlt-1 was significantly higher in preterm preeclampsia than matched control (p < 0.001) and mildly higher in term preeclampsia than matched control (p < 0.01). sFlt-1, sFlt-1/sEGFR and sFlt-1/PLGF were positively correlated with the severity of preterm preeclampsia (P < 0.001, R value ≥ 0.6), especially sFlt-1/sEGFR had the highest R value (R value = 0.711) among them. Furthermore, sEndoglin and the ratio of sEndoglin/sEGFR were associated with neonatal birth weight small for gestational age (SGA, n = 25) in preterm preeclampsia group.
1411 related Products with: The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.Sterile filtered fetal bo Sterile filtered mouse s Sterile filtered fetal bo FDA Standard Frozen Tissu Sterile filtered fetal bo Sterile filtered goat se Sterile filtered fetal bo Sterile filtered human se FDA Standard Frozen Tissu Human interleukin 2(IL-2) MultiGene Gradient therm Sterile filtered fetal bo
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45 Fax 0032 16 50 90 45
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50 Fax 01 43 25 01 60
52062 Aachen Deutschland
Tel 0241 40 08 90 86 Fax 0241 55 91 05 36
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
Schweiz Züri +41435006251
Česká republika Praha +420246019719
Ireland Dublin +35316526556
Norge Oslo +4721031366
Finland Helsset +358942419041
Sverige Stockholm +46852503438
Ελλάς Αθήνα +302111768494
Magyarország Budapest +3619980547
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
Tel 058 710 33 44
Fax 058 710 33 48
GENTAUR Nederland BV
5521 DG Eersel Nederland
Tel 0208-080893 Fax 0497-517897
Piazza Giacomo Matteotti, 6, 24122 Bergamo
Tel 02 36 00 65 93 Fax 02 36 00 65 94
53 Iskar Str. 1191 Kokalyane, Sofia